Financhill
Sell
41

EWTX Quote, Financials, Valuation and Earnings

Last price:
$29.11
Seasonality move :
-22.48%
Day range:
$27.78 - $29.51
52-week range:
$10.60 - $30.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.51x
Volume:
918.3K
Avg. volume:
1.2M
1-year change:
1.43%
Market cap:
$3.1B
Revenue:
--
EPS (TTM):
-$1.58

Earnings Data

Next earnings date for EWTX
Mar 02
2026
Most recent earnings per share
-$0.39
Beat by $0.02
(Nov 6/2025)
Consensus Estimate
-$0.40
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EWTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$0.45 --
03/02/2026 Q4 -- -- -- -$0.44 --
11/06/2025 Q3 -- -- -$0.39 -$0.40 $0.02
08/08/2025 Q2 -- -- -$0.34 -$0.42 $0.07
05/08/2025 Q1 -- -- -$0.43 -$0.42 -$0.01
03/03/2025 Q4 -- -- -$0.42 -$0.42 $0.00
11/07/2024 Q3 -- -- -$0.36 -$0.37 $0.01
08/08/2024 Q2 -- -- -$0.34 -$0.34 $0.01
05/10/2024 Q1 -- -- -$0.33 -$0.41 $0.08
02/22/2024 Q4 -- -- -$0.47 -$0.43 -$0.03
11/09/2023 Q3 -- -- -$0.41 -- --
08/10/2023 Q2 -- -- -$0.34 -- --
05/11/2023 Q1 -- -- -$0.36 -- --
02/23/2023 Q4 -- -- -$0.31 -- --
11/03/2022 Q3 -- -- -$0.34 -- --
08/04/2022 Q2 -- -- -$0.32 -- --
05/11/2022 Q1 -- -- -$0.30 -- --
02/24/2022 Q4 -- -- -$0.26 -- --
11/10/2021 Q3 -- -- -$0.26 -- --
08/09/2021 Q2 -- -- -$0.21 -- --
05/13/2021 Q1 -- -- -$0.14 -- --
12/31/2020 Q4 -- -- -$0.13 -- --
09/30/2020 Q3 -- -- -$0.07 -- --
06/30/2020 Q2 -- -- -$0.08 -- --
03/31/2020 Q1 -- -- -$0.06 -- --

Edgewise Therapeutics, Inc. Earnings Questions

  • How Much did Edgewise Therapeutics, Inc. Generate in Revenue Last Quarter?

    Edgewise Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Edgewise Therapeutics, Inc. Beat Earnings Last Quarter?

    Edgewise Therapeutics, Inc. announced earnings per share of -$0.39 which represents a beat of analyst forecast a -$0.40 per share.

  • Is Edgewise Therapeutics, Inc. Profitable?

    Edgewise Therapeutics, Inc. reported -$570K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Edgewise Therapeutics, Inc. EPS Next Year?

    Edgewise Therapeutics, Inc.'s earnings are forecast to decrease from -$1.45 per share to -$1.60 per share next year representing a decrease of -35.16%.

  • When is Edgewise Therapeutics, Inc.'s Earnings Date?

    Edgewise Therapeutics, Inc.'s next earnings date is March 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 7

Bill Holdings, Inc. [BILL] is up 37.11% over the past day.

Buy
75
PRLB alert for Feb 7

Proto Labs, Inc. [PRLB] is up 28.33% over the past day.

Sell
30
MSTR alert for Feb 7

Strategy, Inc. [MSTR] is up 26.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock